Nobivac NXT HCPCh
Authorised
This medicine is authorised for use in the European Union
feline calicivirosis, feline rhinotracheitis, feline panleucopenia and feline chlamydiosis (live) vaccine
MedicineVeterinaryAuthorised
French is available via eTranslation, the European Commission's machine translation service.
Translate to French | Important information about machine translation
- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website
Product details
- Name of medicine
- Nobivac NXT HCPCh
- Active substance
- chlamydia felis, strain Baker, live
- felid herpesvirus 1, strain G2620A, Live
- feline calicivirus (FCV), strain F9, live
- feline panleucopenia virus (FPL), strain MW-1, live
- International non-proprietary name (INN) or common name
- feline calicivirosis, feline rhinotracheitis, feline panleucopenia and feline chlamydiosis (live) vaccine
Pharmacotherapeutic group
- Immunologicals for felidae
- Live bacterial and viral vaccines
- feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus + chlamydia
Assessment history
News on Nobivac NXT HCPCh
This page was last updated on